SonoThera Inc. has secured a $125 million funding round to advance the development of a nonviral, ultrasound-mediated platform for gene therapy. This marked a major change for a significantly evolving industry
Read MoreSonoThera Inc. has secured a $125 million funding round to advance the development of a nonviral, ultrasound-mediated platform for gene therapy. This marked a major change for a significantly evolving industry
Read More